These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15494852

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association between discoid lupus erythematosus and cigarette smoking.
    Miot HA, Bartoli Miot LD, Haddad GR.
    Dermatology; 2005; 211(2):118-22. PubMed ID: 16088157
    [Abstract] [Full Text] [Related]

  • 3. Discoid lupus erythematosus in children--a retrospective study of 34 patients.
    Sampaio MC, de Oliveira ZN, Machado MC, dos Reis VM, Vilela MA.
    Pediatr Dermatol; 2008; 25(2):163-7. PubMed ID: 18429771
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acetylator phenotype in Iraqi patients with systemic lupus erythematosus.
    Najim RA, Farid YY, Samad TA, Shihab SA.
    East Mediterr Health J; 2005; 11(5-6):1003-8. PubMed ID: 16761671
    [Abstract] [Full Text] [Related]

  • 6. NAT2 acetylator genotypes confer no effect on the risk of developing adult acute leukemia: a case-control study.
    Rollinson S, Roddam P, Willett E, Roman E, Cartwright R, Jack A, Morgan GJ.
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):567-8. PubMed ID: 11352872
    [No Abstract] [Full Text] [Related]

  • 7. [Acetylation phenotype in patients with systemic lupus erythematosus].
    Iakushkevich TN, Tareeva IE, Tuganbekova SK, Kovaleva VL, Evstaf'eva OL.
    Ter Arkh; 1985 May; 57(8):82-4. PubMed ID: 3865448
    [No Abstract] [Full Text] [Related]

  • 8. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM, Abdel-tawab AM, Hassan EA, Mohamed OF.
    Pol J Pharmacol; 2004 May; 56(4):445-9. PubMed ID: 15520499
    [Abstract] [Full Text] [Related]

  • 9. The sex- and age-distributions of chronic discoid lupus erythematosus in four countries. Possible aetiological and pathogenetic significance.
    Burch PR, Rowell NR.
    Acta Derm Venereol; 1968 May; 48(1):33-46. PubMed ID: 4174102
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Antitubercular agents: pharmacogenetic factors in the development of adverse effects].
    Ligueros M, Saavedra H, Neira S, Cruz-Coke R, Saavedra A, Kramer V, Gelman M, Nuñez A, Prieto JC.
    Rev Med Chil; 1990 Jul; 118(7):727-35. PubMed ID: 2131519
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lack of associations of selected variants in genes involved in cell cycle and apoptosis with skin cancer risk.
    Han J, Colditz GA, Hunter DJ.
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):592-3. PubMed ID: 16537723
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The relationship between apolipoprotein E polymorphism, lipoprotein (a) and fatty liver disease.
    Yang MH, Son HJ, Sung JD, Choi YH, Koh KC, Yoo BC, Paik SW.
    Hepatogastroenterology; 2005 Mar; 52(66):1832-5. PubMed ID: 16334787
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.